April 7, 2020

Promising Future of Gene Therapy

Gene therapy is a promising treatment for genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is a suitable treatment for infectious diseases, inherited disease and cancer. The growth of the gene therapy is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others.

DOWNLOAD SAMPLE PDF

Top Companies Involving In This Study:

·         Sangamo Therapeutics, Inc.

·         bluebird bio, Inc.

·         uniQure N.V.

·         AveXis, Inc.

·         Vineti

Gene therapy is the introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of a disease, causing mutations. The gene therapy requires less doses of medicines and is one time treatment, this factor is likely to show growth opportunity for gene therapy market in coming near future.

The gene therapy is segmented based on cell type as, somatic gene therapy and germline gene therapy. The application segment is classified as genetic disorder, cancer, neurological disorder and others. The cancer segment is expected to grow in coming years as the need of gene correction is must as the gene corrector is introduced to produce a another gene or to inhibit the expression of another gene or to disturb the activity of another gene.